Annual CAPEX
N/A
December 1, 2024
Summary
- RARE annual capital expenditures is not available.
Performance
RARE CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CAPEX
N/A
December 1, 2024
Summary
- RARE quarterly capital expenditures is not available.
Performance
RARE Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CAPEX
N/A
December 1, 2024
Summary
- RARE TTM capital expenditures is not available.
Performance
RARE TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
RARE CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
RARE CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Ultragenyx Pharmaceutical CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.62 M(-64.1%) | $20.94 M(-9.0%) |
| Jun 2024 | - | $4.51 M(-65.9%) | $23.02 M(-34.1%) |
| Mar 2024 | - | $13.21 M(+725.7%) | $34.94 M(-25.3%) |
| Dec 2023 | $46.77 M(-68.0%) | $1.60 M(-56.7%) | $46.77 M(-35.2%) |
| Sep 2023 | - | $3.69 M(-77.5%) | $72.14 M(-23.7%) |
| Jun 2023 | - | $16.44 M(-34.3%) | $94.49 M(-13.3%) |
| Mar 2023 | - | $25.03 M(-7.2%) | $108.97 M(-25.4%) |
| Dec 2022 | $146.12 M(+99.9%) | $26.97 M(+3.5%) | $146.12 M(+8.1%) |
| Sep 2022 | - | $26.05 M(-15.8%) | $135.20 M(+4.2%) |
| Jun 2022 | - | $30.92 M(-50.3%) | $129.72 M(+9.1%) |
| Mar 2022 | - | $62.18 M(+287.5%) | $118.86 M(+62.6%) |
| Dec 2021 | $73.09 M(+66.5%) | $16.05 M(-21.9%) | $73.09 M(-7.5%) |
| Sep 2021 | - | $20.56 M(+2.4%) | $78.99 M(+27.0%) |
| Jun 2021 | - | $20.07 M(+22.3%) | $62.21 M(+34.6%) |
| Mar 2021 | - | $16.41 M(-25.2%) | $46.22 M(+5.3%) |
| Dec 2020 | $43.91 M | $21.95 M(+480.6%) | $43.91 M(+31.2%) |
| Sep 2020 | - | $3.78 M(-7.4%) | $33.46 M(-3.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | $4.08 M(-71.0%) | $34.71 M(-3.2%) |
| Mar 2020 | - | $14.10 M(+22.6%) | $35.87 M(+44.4%) |
| Dec 2019 | $24.83 M(+509.2%) | $11.50 M(+128.5%) | $24.83 M(+71.0%) |
| Sep 2019 | - | $5.03 M(-4.0%) | $14.52 M(+38.0%) |
| Jun 2019 | - | $5.24 M(+71.3%) | $10.52 M(+58.0%) |
| Mar 2019 | - | $3.06 M(+156.6%) | $6.66 M(+63.4%) |
| Dec 2018 | $4.08 M(+45.9%) | $1.19 M(+15.5%) | $4.08 M(+7.7%) |
| Sep 2018 | - | $1.03 M(-25.1%) | $3.78 M(-0.0%) |
| Jun 2018 | - | $1.38 M(+189.9%) | $3.78 M(+36.0%) |
| Mar 2018 | - | $475.00 K(-47.2%) | $2.78 M(-0.4%) |
| Dec 2017 | $2.79 M(-72.6%) | $899.00 K(-13.0%) | $2.79 M(+9.1%) |
| Sep 2017 | - | $1.03 M(+174.7%) | $2.56 M(-43.5%) |
| Jun 2017 | - | $376.00 K(-22.5%) | $4.53 M(-50.8%) |
| Mar 2017 | - | $485.00 K(-27.2%) | $9.20 M(+5.6%) |
| Dec 2016 | $10.19 M | $666.00 K(-77.8%) | $8.71 M(+8.3%) |
| Sep 2016 | - | $3.00 M(-40.5%) | $8.04 M(+59.5%) |
| Jun 2016 | - | $5.04 M | $5.04 M |
FAQ
- What is the all time high annual CAPEX for Ultragenyx Pharmaceutical?
- What is the all time high quarterly CAPEX for Ultragenyx Pharmaceutical?
- What is the all time high TTM CAPEX for Ultragenyx Pharmaceutical?
What is the all time high annual CAPEX for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high annual capital expenditures is $146.12 M
What is the all time high quarterly CAPEX for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high quarterly capital expenditures is $62.18 M
What is the all time high TTM CAPEX for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high TTM capital expenditures is $146.12 M